Myriad(MYGN) - 2025 Q4 - Earnings Call Transcript

Myriad Genetics (NasdaqGS:MYGN) Q4 2025 Earnings call February 23, 2026 04:30 PM ET Company ParticipantsAndrew Cooper - Director of Equity Research for Life Science Tools and Services and Diagnostics and Clinical LaboratoriesBen Wheeler - CFOBrian Donnelly - CCOLu Li - Director of Healthcare Equity ResearchMark Verratti - COOMatt Scalo - SVP of Investor RelationsSam Raha - President and CEOConference Call ParticipantsBill Bonello - Senior Research AnalystDan Brennan - Managing Director and Senior Research A ...